Use of IL-1 inhibitors and TNF antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
Details for Australian Patent Application No. 2006228063 (hide)
International Classifications
Event Publications
2 November 2006 Application Open to Public Inspection
Published as AU-B-2006228063
2 November 2006 Complete Application Filed
11 June 2009 Application Accepted
Published as AU-B-2006228063
8 October 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006228064-Method for modulating macrophage activation
2006228062-Device, system and method for dualpath ophthalmic device
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser